Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportMolecular Targeting Probes-Radioactive & Nonradioactive - Preclinical Probes for Oncology

[18F]Brequinar – a potent hDHODH inhibitor for in vivo PET imaging of AML and cancers

Vinay Kumar Banka, Stefano Sainas, Elena Martino, Jiacheng Wang, Marco Lolli and Yu-Shin Ding
Journal of Nuclear Medicine June 2024, 65 (supplement 2) 241785;
Vinay Kumar Banka
1NYU Langone Medical Center
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Stefano Sainas
2University of Torino
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Elena Martino
2University of Torino
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jiacheng Wang
3New York University School of Medicine
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marco Lolli
2University of Torino
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yu-Shin Ding
3New York University School of Medicine
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
Loading

Article Figures & Data

Figures

  • Figure
    • Download figure
    • Open in new tab
    • Download powerpoint
  • Figure
    • Download figure
    • Open in new tab
    • Download powerpoint
Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 65, Issue supplement 2
June 1, 2024
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
[18F]Brequinar – a potent hDHODH inhibitor for in vivo PET imaging of AML and cancers
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
[18F]Brequinar – a potent hDHODH inhibitor for in vivo PET imaging of AML and cancers
Vinay Kumar Banka, Stefano Sainas, Elena Martino, Jiacheng Wang, Marco Lolli, Yu-Shin Ding
Journal of Nuclear Medicine Jun 2024, 65 (supplement 2) 241785;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
[18F]Brequinar – a potent hDHODH inhibitor for in vivo PET imaging of AML and cancers
Vinay Kumar Banka, Stefano Sainas, Elena Martino, Jiacheng Wang, Marco Lolli, Yu-Shin Ding
Journal of Nuclear Medicine Jun 2024, 65 (supplement 2) 241785;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Figures & Data
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • A Dimeric SV2A-Targeting Conjugate with Albumin Binding Towards Theranostic Application in Cancer with Neuroendocrine Differentiation
  • Development of a novel TKI-PET probe targeting EGFR mutation
  • PD-L1 imaging and T cell imaging jointly achieve precise combination therapy of radiotherapy and immunotherapy
Show more Molecular Targeting Probes-Radioactive & Nonradioactive - Preclinical Probes for Oncology

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire